Skip to main content
Log in

Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Facioscapulohumeral muscular dystrophy (FSHD), an autosomal dominant neuromuscular disorder, has been causally related to deletion of tandemly arrayed 3.3 kb repeats (D4Z4) on chromosome 4q35. Although increased expression of several 4q35 genes has been reported, two recent studies dispute this, finding no significant changes in the transcriptional level of any of the 4q35 genes, among which is the heart and muscle-specific isoform of the adenine nucleotide translocator (ANT1). We found markedly increased levels of ANT1 protein in both unaffected and affected FSHD muscles in comparison to control healthy muscles. Comparative protein expression analysis between healthy, Duchenne muscular dystrophy, and FSHD muscle shows that proteins involved in mitochondrial function and protection from oxidative stress are also reproducibly and specifically modified in all FSHD muscles, including clinically unaffected muscles. Increased ANT1 expression and mitochondrial dysfunction may thus be initial events in FSHD pathogenesis and represent potential therapeutic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

2-DE :

Two-dimensional gel electrophoresis

ANT :

Adenine nucleotide translocator

DMD :

Duchenne muscular dystrophy

FSHD :

Facioscapulohumeral muscular dystrophy

MALDI-TOF :

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

PAGE :

Polyacrylamide gel electrophoresis

pI :

Isoelectric point

ROS :

Reactive oxygen species

SDS :

Sodium dodecyl sulfate

SOD :

Cu/Zn superoxide dismutase

References

  1. Munsat T (1994) Facioscapulohumeral dystrophy and the scapuloperoneal syndrome. In: Engel AG, Banker BQ (eds) Myologie. McGraw-Hill, New York, pp 1220–1232

  2. Gilbert JR, Stajich JM, Speer MC, Vance JM, Stewart CS, Yamaoka LH, Samson F, Fardeau M, Potter TG, Roses AD et al (1992) Linkage studies in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 51:424–7

    CAS  PubMed  Google Scholar 

  3. Nakagawa M, Higuchi I, Yoshidome H, Isashiki Y, Ohkubo R, Kaseda S, Iwaki H, Fukunaga H, Osame M (1996) Familial facioscapulohumeral muscular dystrophy: phenotypic diversity and genetic abnormality. Acta Neurol Scand 93:189–192

    CAS  PubMed  Google Scholar 

  4. Nakagawa M, Matsuzaki T, Higuchi I, Fukunaga H, Inui T, Nagamitsu S, Yamada H, Arimura K, Osame M (1997) Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients. Intern Med 36:333–339

    CAS  PubMed  Google Scholar 

  5. Lunt PW, Compston DA, Harper PS (1989) Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias. J Med Genet 26:755–760

    CAS  PubMed  Google Scholar 

  6. Mathews KD, Mills KA, Bosch EP, Ionasescu VV, Wiles KR, Buetow KH, Murray JC (1992) Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35. Am J Hum Genet 51:428–431

    CAS  PubMed  Google Scholar 

  7. Sarfarazi M, Wijmenga C, Upadhyaya M, Weiffenbach B, Hyser C, Mathews K, Murray J, Gilbert J, Pericak-Vance M, Lunt Pet al (1992) Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet 51:396–403

    CAS  PubMed  Google Scholar 

  8. Upadhyaya M, Osborn M, Maynard J, Altherr M, Ikeda J, Harper PS (1995) Towards the finer mapping of facioscapulohumeral muscular dystrophy at 4q35: construction of a laser microdissection library. Am J Med Genet 60:244–251

    CAS  PubMed  Google Scholar 

  9. Weiffenbach B, Bagley R, Falls K, Hyser C, Storvick D, Jacobsen SJ, Schultz P, Mendell J, Willems van Dijk K, Milner EC et al (1992) Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35. Am J Hum Genet 51:416–423

    CAS  PubMed  Google Scholar 

  10. Winokur ST, Schutte B, Weiffenbach B, Washington SS, McElligott D, Chakravarti A, Wasmuth JH, Altherr MR (1993) A radiation hybrid map of 15 loci on the distal long arm of chromosome 4, the region containing the gene responsible for facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 53:874–880

    CAS  PubMed  Google Scholar 

  11. Wijmenga C, Padberg GW, Moerer P, Wiegant J, Liem L, Brouwer OF, Milner EC, Weber JL, van Ommen GB, Sandkuyl LA et al (1991) Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics 9:570–575

    CAS  PubMed  Google Scholar 

  12. Lee JH, Goto K, Matsuda C, Arahata K (1995) Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35. Muscle Nerve 2:6–13

    Google Scholar 

  13. van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH, Frants RR (1993) FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 2:2037–2042

    PubMed  Google Scholar 

  14. Wijmenga C, van Deutekom JC, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH, Frants RR (1994) Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics 19:21–26

    Article  CAS  PubMed  Google Scholar 

  15. Lunt PW, Jardine PE, Koch M, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle Nerve 2:103–109

    Google Scholar 

  16. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 4:951–958

    CAS  PubMed  Google Scholar 

  17. Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744–748

    CAS  PubMed  Google Scholar 

  18. Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen Det al (1999) Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236:25–32

    Article  CAS  PubMed  Google Scholar 

  19. Tupler R, Perini G, Pellegrino MA, Green MR (1999) Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc Natl Acad Sci USA 96:12650–12654

    Article  CAS  PubMed  Google Scholar 

  20. Gabellini D, Green MR, Tupler R (2002) Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339–348

    Article  CAS  PubMed  Google Scholar 

  21. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12:2895–2907

    Article  CAS  PubMed  Google Scholar 

  22. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M (2003) Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 12:2909–2921

    Article  CAS  PubMed  Google Scholar 

  23. Laoudj-Chenivesse D, Marin P, Bennes R, Tronel-Peyroz E, Leterrier F (2002) High performance two-dimensional gel electrophoresis using a wetting agent Tergitol (R) NP7. Proteomics 2:481–485

    Article  CAS  PubMed  Google Scholar 

  24. Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Boucherie H, Mann M (1996) Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 93:14440–14445

    Article  CAS  PubMed  Google Scholar 

  25. Bauer MK, Schubert A, Rocks O. Grimm S (1999) Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 147:1493–1502

    Article  CAS  PubMed  Google Scholar 

  26. Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, Rossini K, Carraro U, Angelini C (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 60:302–312

    CAS  PubMed  Google Scholar 

  27. Packer L (1995) Oxidative stress and aging, Birkhauser, Basel

  28. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medecine. Clarenton, Oxford, pp 86–135

  29. Giometti CS, Anderson NG (1981) Muscle protein analysis. III. Analysis of solubilized frozen-tissue sections by two-dimensional electrophoresis. Clin Chem 27:1918–1921

    Google Scholar 

  30. Giometti CS (1982) Muscle protein analysis by two-dimensional gel electrophoresis. Crit Rev Clin Lab Sci 18:79–109

    CAS  PubMed  Google Scholar 

  31. Giometti CS, Danon MJ, Anderson NG (1983) Human muscle proteins: analysis by two-dimensional electrophoresis. Neurology 33:1152–1156

    CAS  PubMed  Google Scholar 

  32. Giometti CS, Gemmell MA, Anderson NL (1985) Two different variants of the same tropomyosin polypeptide in clones from GM1386 human skin fibroblasts. Biochem Biophys Res Commun 128:1247–1253

    CAS  PubMed  Google Scholar 

  33. Giometti CS, Danon MJ (1990) The expression of myosin light chains and tropomyosin in human muscle biopsies with histochemical type 1 and type 2 fiber deficiency. Muscle Nerve 13:209–214

    CAS  PubMed  Google Scholar 

  34. van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 35:315–317

    Article  PubMed  Google Scholar 

  35. Yan LJ, Sohal RS (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 95:12896–12901

    Article  CAS  PubMed  Google Scholar 

  36. Wallace DC, Brown MD, Melov S, Graham B, Lott M (1998) Mitochondrial biology, degenerative diseases and aging. Biofactors 7:187–190

    CAS  PubMed  Google Scholar 

  37. Wallace DC, Melov S (1998) Radicals r’aging. Nat Genet 19:105–106

    Article  CAS  PubMed  Google Scholar 

  38. Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527–605

    CAS  PubMed  Google Scholar 

  39. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ (2000) Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192:1001–1014

    Article  CAS  PubMed  Google Scholar 

  40. Wang P, Chen H, Qin H, Sankarapandi S, Becher MW, Wong PC, Zweier JL (1998) Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 95:4556–4560

    Article  CAS  PubMed  Google Scholar 

  41. Merad-Saidoune M, Boitier E, Nicole A, Marsac C, Martinou JC, Sola B, Sinet PM, Ceballos-Picot I (1999) Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion. Exp Neurol 158:428–436

    Article  CAS  PubMed  Google Scholar 

  42. DiMauro S, Bonilla E (1997) The molecular and genetic basis of neurological disease. Butterworth-Helnemann, Boston

  43. Trounce I, Byrne E, Marzuki S (1989) Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet I:637–639

    Article  Google Scholar 

  44. Stadtman ER, Berlett DL (1999) In: Gilbert DL, Colton CA (eds) Reactive oxygen species in biological systems. Kluwer/Plenum, New York, pp 657–675

  45. Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the patients from the Association FSH Europe who continuously helped and supported this study. We thank the Banque de Tissus pour la Recherche of the Association Française contre les Myopathies and Dr. Frederic Laude for providing control and FSHD muscle biopsies. We wish to thank Dr. François Leterrier for his continuous interest and active support for this work. We are extremely grateful to Dr. Ned Lamb and Dr. Dominique Mornet for their encouragements. This work was supported by Association Française contre les Myopathies, the Centre National de la Recherche Scientifique and the Muscular Dystrophy Association (MDA3695).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dalila Laoudj-Chenivesse.

Additional information

This work is dedicated to the memory of Dr. Rene Bennes who accompanied it with faith, continuous help, and positive input

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laoudj-Chenivesse, D., Carnac, G., Bisbal, C. et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med 83, 216–224 (2005). https://doi.org/10.1007/s00109-004-0583-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-004-0583-7

Keywords

Navigation